New Bill Proposes Solution to CBD Regulation

On January 13, 2020, the chairman of the U.S. House Committee on Agriculture, Representative Collin Peterson (D-MN), introduced a bill to address one of the largest issues in the burgeoning hemp industry – the regulation of cannabidiol (“CBD”). H.R.5587 aims to amend existing legislation to grant … Read more about New Bill Proposes Solution to CBD Regulation

Westword Publishes Managing Partner’s Article on CBD & Schedule I

Nearly a year after the passing of the Agriculture Improvement Act of 2018 (“2018 Farm Bill”), the industrial hemp and cannabidiol (“CBD”) markets are booming, yet ingestible products are still illegal according to the federal government. With mounting pressure on the U.S. Food and Drug … Read more about Westword Publishes Managing Partner’s Article on CBD & Schedule I

SAFE Banking Act Passes in the House

  Late Wednesday, the U.S. House of Representatives passed the first-ever self-contained cannabis bill, clearing H.R.1595 – or the  Secure And Fair Enforcement Banking Act of 2019 (“SAFE Banking Act”) – in a bipartisan 321-103 vote. Introduced by Colorado Representative Ed Perlmutter (D) … Read more about SAFE Banking Act Passes in the House

Recent FTC Warning Letters Target CBD Medical Claims

September 10, 2019, the U.S. Federal Trade Commission (“FTC”) issued a news release announcing the recent distribution of warning letters to three companies advertising cannabidiol (“CBD”) products as a medical treatment option for a range of various illnesses. Cautioning that such unsubstantiated … Read more about Recent FTC Warning Letters Target CBD Medical Claims

Proposed California CBD Bill Suspended

Contrary to the bill’s projected outcome from earlier in the summer, California lawmakers will not make a decision on Assembly Bill-228 (“AB 228”) this year as the bill has stalled in the state legislature despite broad bipartisan interest and consumer support. Previously expected to be signed into … Read more about Proposed California CBD Bill Suspended

FDA Plans Release of CBD Regulations by Fall 2019

Cannabidiol (“CBD”) products have gained popularity across the country, but clear regulation from the Food and Drug Administration (“FDA”) is still forthcoming. This July, FDA announced an intent to fast- track the process to create these much-needed regulations. Currently, nearly 90% of CBD … Read more about FDA Plans Release of CBD Regulations by Fall 2019

Revisiting the War on Drugs & Its Impact

July 14 marked the 50th anniversary of President Richard Nixon’s message to Congress asking for the establishment of a federal plan to tackle substance abuse, citing a dramatic increase in juvenile arrests for drug offenses. Nixon’s letter was the start of a new era of American drug policy as, the … Read more about Revisiting the War on Drugs & Its Impact

Largest U.S. CBD Company Hit with Warning Letter from FDA

On July 22, 2019, the United States Food and Drug Administration (“FDA”) sent a Warning Letter (the “Letter”) to Curaleaf, Inc. notifying the company that FDA considers several products Curaleaf sells on its website, specifically its  “CBD Lotion,” “CBD Pain-Relief Patch,” five versions of its “CBD … Read more about Largest U.S. CBD Company Hit with Warning Letter from FDA